Insecticide resistance and the limits of our current vector control tools threaten our global progress against vector-borne diseases. Innovative vector control tools are therefore urgently needed, but some technical, financial and programmatic barriers may hinder innovation. In October 2011, a gathering of stakeholders including individuals from IVCC, WHO, donor institutions, industry, and other partners issued a joint call for a mapping of the current process to introduce new vector control tools for public health and the need to identify the challenges faced today in this process.
Bayesian mixed treatment comparisons of a network of connected randomized trials with repeated measurements of the primary categorical outcome allowed to take into account both the individual- and between- studies sources of heterogeneity.
In the present study, dengue and malaria co-infection clinical picture seems to be more severe than single infections in French Guiana, with a greater risk of deep thrombocytopaenia and anaemia.
We aimed to understand how malaria tests and antimalarial drugs are currently used as part of social interactions between health workers and patients at public and mission health facilities in Yaoundé and Bamenda and surrounding districts in the Northwest region of Cameroon.
These data highlight the absolute necessity of confirming all reported malaria cases by biological diagnosis methods, to increase the accuracy of the malaria indicators used in monitoring and evaluation processes and to improve patient care in the more remote areas of Niger.
WHO estimates that 80% of mortality due to malaria occurs among infants and young children.
Integrated vector management (IVM) is a rational decision-making process for ensuring optimal use of resources for vector control.
Our findings show that the malaria mortality burden is larger than previously estimated, especially in adults.
The scale-up of malaria control efforts in recent years, coupled with major investments in malaria research, has produced impressive public health impact in a number of countries and has led to the development of new tools and strategies aimed at further consolidating malaria control goals.
Malaria, caused by Plasmodium sp, results in almost one million deaths and over 200 million new infections annually.